<p>Quantinno Capital Management LP 在最近向證券交易委員會提交的文件中表示，在第二季度將其在美敦力公司（NYSE:MDT - 免費報告）的股份增加了 42.1%。該基金在此期間購買了額外的 123,691 股後，持有該醫療技術公司 417,488 股股票。根據其最近向證券交易委員會提交的文件，Quantinno Capital Management LP 在美敦力的持股價值為 36,392,000 美元。</p>
<ul>
<li>美敦力股票找到支撐——現在正在獲得動能</li>
</ul>
<p>其他機構投資者最近也買賣了該公司的股票。Brighton Jones LLC 在第四季度將其在美敦力的持股比例提高了 1,368.0%。Brighton Jones LLC 現在擁有 39,989 股美敦力的股票，價值 3,194,000 美元，此前在上個季度又收購了 37,265 股。Rathbones Group PLC 在第一季度將其在美敦力的股份增加了 43.6%。Rathbones Group PLC 現在擁有 8,131 股美敦力的股票，價值 731,000 美元，此前在上個季度又購買了 2,468 股。Vestmark Advisory Solutions Inc.在第一季度將其在美敦力的持股增加了 98.4%。Vestmark Advisory Solutions Inc.現在擁有 8,746 股美敦力的股票，價值 786,000 美元，此前在上個季度又購買了 4,338 股。Kovitz Investment Group Partners LLC 在第一季度將其在美敦力的持股提高了 43.8%。Kovitz Investment Group Partners LLC 現在擁有 108,030 股美敦力的股票，價值 9,708,000 美元，此前在上個季度又購買了 32,907 股。最後，Inspire Trust Co. N.A.在第一季度將其在美敦力的股份提高了 4.5%。Inspire Trust Co. N.A.現在擁有 46,000 股美敦力的股票，價值 4,134,000 美元，此前在上個季度又購買了 2,000 股。目前，82.06% 的股票由機構投資者和對沖基金持有。</p>
<h2>華爾街分析師觀點</h2>
<p>幾家研究公司最近對 MDT 發佈了報告。摩根大通將美敦力的股票目標價從 90.00 美元上調至 100.00 美元，並在 11 月 13 日的研究報告中給予該股票 “中性” 評級。Sanford C. Bernstein 在 11 月 19 日的報告中設定了美敦力的目標價為 111.00 美元。富國銀行在 11 月 19 日的研究報告中將美敦力的目標價從 100.00 美元上調至 114.00 美元，並給予該公司 “增持” 評級。Robert W. Baird 在 11 月 19 日的研究報告中將美敦力的目標價從 103.00 美元上調至 109.00 美元，並給予該股票 “中性” 評級。最後，瑞銀集團在 11 月 19 日的研究報告中將美敦力的目標價從 95.00 美元上調至 102.00 美元，並給予該公司 “中性” 評級。一位分析師對該股票給予了強烈買入評級，十三位分析師給予買入評級，十二位分析師給予持有評級。根據 MarketBeat.com 的數據，該公司的平均評級為 “適度買入”，共識目標價為 110.44 美元。</p>
<ul>
<li>MarketBeat 週迴顧 – 08/18 - 08/22</li>
</ul>
<p><strong>查看我們最新的美敦力股票報告</strong></p>
<h2>美敦力股價下跌 1.0%</h2>
<p>美敦力（NYSE:MDT）股票週五開盤價為 99.77 美元。該公司的流動比率為 2.42，速動比率為 1.80，債務與股本比率為 0.57。該股票的市值為 1279.1 億美元，市盈率為 26.89，市盈增長比率為 2.65，貝塔值為 0.71。美敦力 PLC 的 12 個月低點為 79.29 美元，12 個月高點為 106.33 美元。該股票的 50 日簡單移動平均線為 97.23 美元，200 日簡單移動平均線為 92.66 美元。</p>
<ul>
<li>美敦力：收入投資者的機會變得更好</li>
</ul>
<p>美敦力（NYSE:MDT - 獲取免費報告）最後一次公佈財報是在 11 月 18 日，醫療技術公司報告季度每股收益為 1.36 美元，超出分析師一致預期的 1.31 美元，超出 0.05 美元。該公司在本季度的收入為 89.6 億美元，而分析師預期為 88.6 億美元。美敦力的股本回報率為 14.86%，淨利潤率為 13.71%。美敦力本季度的收入同比增長 6.6%。去年同期，該公司每股收益為 1.26 美元。美敦力已將其 2026 財年的指引設定為 5.620-5.660 每股收益。分析師平均預測美敦力 PLC 在當前年度的每股收益為 5.46 美元。</p>
<h2>美敦力分紅公告</h2>
<p>該公司還最近宣佈了一項季度分紅，將於 1 月 16 日（星期五）支付。12 月 26 日（星期五）的登記投資者將獲得每股 0.71 美元的分紅。這相當於每年 2.84 美元的分紅，收益率為 2.8%。該分紅的除息日期為 12 月 26 日（星期五）。美敦力的分紅支付比率目前為 76.55%。</p>
<h2>關於美敦力</h2>
<p>（免費報告）</p>
<p>美敦力公司開發、製造和銷售基於設備的醫療療法，服務於全球的醫療系統、醫生、臨牀醫生和患者。其心血管產品組合提供可植入的心臟起搏器、心臟復律除顫器和心臟再同步治療設備；心臟消融產品；可植入心臟監測系統；TYRX 產品；以及遠程監測和以患者為中心的軟件。</p>
<h2>精選故事</h2>
<ul>
<li>五隻我們更看好的股票超過美敦力</li>
<li>寶潔公司（NYSE: PG）在不穩定的指引後回落</li>
<li>分紅強勢股：3 只為長期投資而打造的藍籌股</li>
<li>3 只可以提升您投資組合的家居改善股票</li>
<li>3 只最近被下調評級的股票，2026 年應避免</li>
<li>FAANG 股票是什麼？它們是好的投資嗎？</li>
<li>芯片熱潮迴歸：3 只有望獲得巨大收益的股票</li>
</ul>
<p><strong>想知道其他對沖基金持有 MDT 的情況嗎？</strong> 請訪問 HoldingsChannel.com 獲取 Medtronic PLC (NYSE:MDT - 免費報告) 的最新 13F 文件和內部交易信息。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1EVA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1EVA"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，旨在為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在 Medtronic 嗎？</h2>
<p>在考慮 Medtronic 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而 Medtronic 並不在名單上。</p>
<p>雖然 Medtronic 目前在分析師中有中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

美敦力

<p>Quantinno Capital Management LP 在第二季度增持了美敦力（Medtronic PLC）42.1% 的股份，持有 417,488 股，價值 3639 萬美元。分析師們發佈了各種評級，普遍目標價為 110.44 美元。美敦力的股票開盤價為 99.77 美元，市值為 1279.1 億美元。該公司報告第二季度每股收益為 1.36 美元，超出預期</p>

<p>Quantinno Capital Management LP increased its stake in shares of Medtronic PLC (NYSE:MDT - Free Report) by 42.1% in the 2nd quarter, according to the company in its most recent filing with the Securities &amp; Exchange Commission. The fund owned 417,488 shares of the medical technology company's stock after purchasing an additional 123,691 shares during the period. Quantinno Capital Management LP's holdings in Medtronic were worth $36,392,000 as of its most recent filing with the Securities &amp; Exchange Commission.</p>
<div class="lb-trans"><p>Quantinno Capital Management LP 在最近向證券交易委員會提交的文件中表示，在第二季度將其在美敦力公司（NYSE:MDT - 免費報告）的股份增加了 42.1%。該基金在此期間購買了額外的 123,691 股後，持有該醫療技術公司 417,488 股股票。根據其最近向證券交易委員會提交的文件，Quantinno Capital Management LP 在美敦力的持股價值為 36,392,000 美元。</p>
</div><ul>
<li>Medtronic Stock Finds Its Footing—Now It’s Gaining Momentum</li>
</ul>
<div class="lb-trans"><ul>
<li>美敦力股票找到支撐——現在正在獲得動能</li>
</ul>
</div><p>Other institutional investors also recently bought and sold shares of the company. Brighton Jones LLC lifted its position in shares of Medtronic by 1,368.0% in the fourth quarter. Brighton Jones LLC now owns 39,989 shares of the medical technology company's stock valued at $3,194,000 after acquiring an additional 37,265 shares in the last quarter. Rathbones Group PLC boosted its stake in Medtronic by 43.6% during the 1st quarter. Rathbones Group PLC now owns 8,131 shares of the medical technology company's stock worth $731,000 after purchasing an additional 2,468 shares during the last quarter. Vestmark Advisory Solutions Inc. grew its holdings in shares of Medtronic by 98.4% during the first quarter. Vestmark Advisory Solutions Inc. now owns 8,746 shares of the medical technology company's stock worth $786,000 after buying an additional 4,338 shares in the last quarter. Kovitz Investment Group Partners LLC raised its position in shares of Medtronic by 43.8% in the first quarter. Kovitz Investment Group Partners LLC now owns 108,030 shares of the medical technology company's stock valued at $9,708,000 after buying an additional 32,907 shares during the last quarter. Finally, Inspire Trust Co. N.A. lifted its stake in Medtronic by 4.5% in the 1st quarter. Inspire Trust Co. N.A. now owns 46,000 shares of the medical technology company's stock worth $4,134,000 after purchasing an additional 2,000 shares in the last quarter. 82.06% of the stock is currently owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>其他機構投資者最近也買賣了該公司的股票。Brighton Jones LLC 在第四季度將其在美敦力的持股比例提高了 1,368.0%。Brighton Jones LLC 現在擁有 39,989 股美敦力的股票，價值 3,194,000 美元，此前在上個季度又收購了 37,265 股。Rathbones Group PLC 在第一季度將其在美敦力的股份增加了 43.6%。Rathbones Group PLC 現在擁有 8,131 股美敦力的股票，價值 731,000 美元，此前在上個季度又購買了 2,468 股。Vestmark Advisory Solutions Inc.在第一季度將其在美敦力的持股增加了 98.4%。Vestmark Advisory Solutions Inc.現在擁有 8,746 股美敦力的股票，價值 786,000 美元，此前在上個季度又購買了 4,338 股。Kovitz Investment Group Partners LLC 在第一季度將其在美敦力的持股提高了 43.8%。Kovitz Investment Group Partners LLC 現在擁有 108,030 股美敦力的股票，價值 9,708,000 美元，此前在上個季度又購買了 32,907 股。最後，Inspire Trust Co. N.A.在第一季度將其在美敦力的股份提高了 4.5%。Inspire Trust Co. N.A.現在擁有 46,000 股美敦力的股票，價值 4,134,000 美元，此前在上個季度又購買了 2,000 股。目前，82.06% 的股票由機構投資者和對沖基金持有。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>華爾街分析師觀點</h2>
</div><p>Several research firms recently issued reports on MDT. JPMorgan Chase &amp; Co. raised their price objective on shares of Medtronic from $90.00 to $100.00 and gave the stock a &#34;neutral&#34; rating in a research report on Thursday, November 13th. Sanford C. Bernstein set a $111.00 price target on shares of Medtronic in a report on Wednesday, November 19th. Wells Fargo &amp; Company lifted their price target on shares of Medtronic from $100.00 to $114.00 and gave the company an &#34;overweight&#34; rating in a research report on Wednesday, November 19th. Robert W. Baird increased their price objective on Medtronic from $103.00 to $109.00 and gave the stock a &#34;neutral&#34; rating in a research report on Wednesday, November 19th. Finally, UBS Group lifted their target price on Medtronic from $95.00 to $102.00 and gave the company a &#34;neutral&#34; rating in a research report on Wednesday, November 19th. One analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and twelve have given a Hold rating to the company's stock. Based on data from MarketBeat.com, the company has an average rating of &#34;Moderate Buy&#34; and a consensus target price of $110.44.</p>
<div class="lb-trans"><p>幾家研究公司最近對 MDT 發佈了報告。摩根大通將美敦力的股票目標價從 90.00 美元上調至 100.00 美元，並在 11 月 13 日的研究報告中給予該股票 “中性” 評級。Sanford C. Bernstein 在 11 月 19 日的報告中設定了美敦力的目標價為 111.00 美元。富國銀行在 11 月 19 日的研究報告中將美敦力的目標價從 100.00 美元上調至 114.00 美元，並給予該公司 “增持” 評級。Robert W. Baird 在 11 月 19 日的研究報告中將美敦力的目標價從 103.00 美元上調至 109.00 美元，並給予該股票 “中性” 評級。最後，瑞銀集團在 11 月 19 日的研究報告中將美敦力的目標價從 95.00 美元上調至 102.00 美元，並給予該公司 “中性” 評級。一位分析師對該股票給予了強烈買入評級，十三位分析師給予買入評級，十二位分析師給予持有評級。根據 MarketBeat.com 的數據，該公司的平均評級為 “適度買入”，共識目標價為 110.44 美元。</p>
</div><ul>
<li>MarketBeat Week in Review – 08/18 - 08/22</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 週迴顧 – 08/18 - 08/22</li>
</ul>
</div><p><strong>View Our Latest Stock Report on MDT</strong></p>
<div class="lb-trans"><p><strong>查看我們最新的美敦力股票報告</strong></p>
</div><h2>Medtronic Trading Down 1.0%</h2>
<div class="lb-trans"><h2>美敦力股價下跌 1.0%</h2>
</div><p>Shares of NYSE MDT opened at $99.77 on Friday. The company has a current ratio of 2.42, a quick ratio of 1.80 and a debt-to-equity ratio of 0.57. The stock has a market capitalization of $127.91 billion, a PE ratio of 26.89, a PEG ratio of 2.65 and a beta of 0.71. Medtronic PLC has a twelve month low of $79.29 and a twelve month high of $106.33. The stock has a fifty day simple moving average of $97.23 and a 200-day simple moving average of $92.66.</p>
<div class="lb-trans"><p>美敦力（NYSE:MDT）股票週五開盤價為 99.77 美元。該公司的流動比率為 2.42，速動比率為 1.80，債務與股本比率為 0.57。該股票的市值為 1279.1 億美元，市盈率為 26.89，市盈增長比率為 2.65，貝塔值為 0.71。美敦力 PLC 的 12 個月低點為 79.29 美元，12 個月高點為 106.33 美元。該股票的 50 日簡單移動平均線為 97.23 美元，200 日簡單移動平均線為 92.66 美元。</p>
</div><ul>
<li>Medtronic: The Opportunity Gets Healthier for Income Investors</li>
</ul>
<div class="lb-trans"><ul>
<li>美敦力：收入投資者的機會變得更好</li>
</ul>
</div><p>Medtronic (NYSE:MDT - Get Free Report) last announced its earnings results on Tuesday, November 18th. The medical technology company reported $1.36 EPS for the quarter, beating analysts' consensus estimates of $1.31 by $0.05. The company had revenue of $8.96 billion during the quarter, compared to analysts' expectations of $8.86 billion. Medtronic had a return on equity of 14.86% and a net margin of 13.71%.Medtronic's revenue for the quarter was up 6.6% on a year-over-year basis. During the same period last year, the business posted $1.26 EPS. Medtronic has set its FY 2026 guidance at 5.620-5.660 EPS. On average, equities analysts forecast that Medtronic PLC will post 5.46 earnings per share for the current year.</p>
<div class="lb-trans"><p>美敦力（NYSE:MDT - 獲取免費報告）最後一次公佈財報是在 11 月 18 日，醫療技術公司報告季度每股收益為 1.36 美元，超出分析師一致預期的 1.31 美元，超出 0.05 美元。該公司在本季度的收入為 89.6 億美元，而分析師預期為 88.6 億美元。美敦力的股本回報率為 14.86%，淨利潤率為 13.71%。美敦力本季度的收入同比增長 6.6%。去年同期，該公司每股收益為 1.26 美元。美敦力已將其 2026 財年的指引設定為 5.620-5.660 每股收益。分析師平均預測美敦力 PLC 在當前年度的每股收益為 5.46 美元。</p>
</div><h2>Medtronic Dividend Announcement</h2>
<div class="lb-trans"><h2>美敦力分紅公告</h2>
</div><p>The firm also recently announced a quarterly dividend, which will be paid on Friday, January 16th. Investors of record on Friday, December 26th will be paid a dividend of $0.71 per share. This represents a $2.84 annualized dividend and a yield of 2.8%. The ex-dividend date of this dividend is Friday, December 26th. Medtronic's dividend payout ratio is presently 76.55%.</p>
<div class="lb-trans"><p>該公司還最近宣佈了一項季度分紅，將於 1 月 16 日（星期五）支付。12 月 26 日（星期五）的登記投資者將獲得每股 0.71 美元的分紅。這相當於每年 2.84 美元的分紅，收益率為 2.8%。該分紅的除息日期為 12 月 26 日（星期五）。美敦力的分紅支付比率目前為 76.55%。</p>
</div><h2>About Medtronic</h2>
<div class="lb-trans"><h2>關於美敦力</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免費報告）</p>
</div><p>Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.</p>
<div class="lb-trans"><p>美敦力公司開發、製造和銷售基於設備的醫療療法，服務於全球的醫療系統、醫生、臨牀醫生和患者。其心血管產品組合提供可植入的心臟起搏器、心臟復律除顫器和心臟再同步治療設備；心臟消融產品；可植入心臟監測系統；TYRX 產品；以及遠程監測和以患者為中心的軟件。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精選故事</h2>
</div><ul>
<li>Five stocks we like better than Medtronic</li>
<li>Procter &amp; Gamble NYSE: PG Pulls Back After Shaky Guidance</li>
<li>Dividend Powerhouses: 3 Blue-Chip Stocks Built for the Long Haul</li>
<li>3 Home Improvement Stocks that Can Upgrade Your Portfolio</li>
<li>3 Recently Downgraded Stocks to Avoid in 2026</li>
<li>What Are the FAANG Stocks and Are They Good Investments?</li>
<li>The Chip Boom Is Back: 3 Stocks Positioned for Huge Gains</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票超過美敦力</li>
<li>寶潔公司（NYSE: PG）在不穩定的指引後回落</li>
<li>分紅強勢股：3 只為長期投資而打造的藍籌股</li>
<li>3 只可以提升您投資組合的家居改善股票</li>
<li>3 只最近被下調評級的股票，2026 年應避免</li>
<li>FAANG 股票是什麼？它們是好的投資嗎？</li>
<li>芯片熱潮迴歸：3 只有望獲得巨大收益的股票</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding MDT?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medtronic PLC (NYSE:MDT - Free Report).</p>
<div class="lb-trans"><p><strong>想知道其他對沖基金持有 MDT 的情況嗎？</strong> 請訪問 HoldingsChannel.com 獲取 Medtronic PLC (NYSE:MDT - 免費報告) 的最新 13F 文件和內部交易信息。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1EVA" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=MDT"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，旨在為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Medtronic Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Medtronic 嗎？</h2>
</div><p>Before you consider Medtronic, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Medtronic 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Medtronic wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而 Medtronic 並不在名單上。</p>
</div><p>While Medtronic currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Medtronic 目前在分析師中有中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Quantinno Capital Management LP 收購了美敦力公司 $MDT 的股票